03Recent Activity
Portfolio company Peloton Therapeutics was acquired by Merck for up to $2.2B, bolstering its oncology pipeline.
MAY 12, 2019
Peloton Therapeutics secured $150M in Series E financing.
FEB 14, 2019
Peloton Therapeutics is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary drug discovery platform
Peloton Therapeutics is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary drug discovery platform.